logo

For the Inventor, By the Inventor

Solon, OH, United States of America

Syed M Ali

This inventor holds 6 USPTO granted patents. Top assignees: Gliatech, Inc., Merck + Co., Inc.. Active years: 1999-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Syed M Ali. Retrieved from https://idiyas.com/inventor/syed-m-ali-0a69gwwp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 66.7

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal3 out of 17 
 
Gliatech, Inc.
 patents
silverMedal3 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1999-2006

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7049343 - Substituted hydrazine derivatives (2006-05-23),
2. 6946474 - Nitrogen-containing compounds and their use as glycine transport inhibitors (2005-09-20),
3. 6794405 - Alicyclic imidazoles as H3 agents (2004-09-21),
4. 6448282 - 1H-4(5)-substituted imidazole derivatives (2002-09-10),
5. 6166060 - 1H-4(5)-substituted imidazole derivatives (2000-12-26),
6. 6008240 - 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives (1999-12-28),

Title: Syed M Ali: Innovator in Glycine Transport Inhibition

Introduction

Syed M Ali is a notable inventor based in Solon, OH (US), recognized for his contributions to the field of glycine transport inhibition. With a total of six patents to his name, he has made significant advancements in pharmaceutical compositions and methods for treating disease states related to glycine.

Latest Patents

Among his latest patents, Ali has developed methods involving substituted hydrazine derivatives aimed at inhibiting high-affinity glycine transporters. These patents disclose compounds that not only inhibit these transporters but also include pharmaceutically active compositions for controlling or preventing disease states associated with glycine. Another significant patent focuses on nitrogen-containing compounds, specifically trichloroethyl-sulfonylurea-containing compounds, which serve as glycine transport inhibitors. This invention outlines pharmaceutical compositions and methods for utilizing these compounds in treating various disease states linked to glycine.

Career Highlights

Throughout his career, Syed M Ali has worked with prominent companies such as Gliatech, Inc. and Merck & Company, Inc. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and innovation in glycine transport research.

Collaborations

Some of his notable coworkers include James G Phillips and Clark E Tedford, who have collaborated with him on various projects and research initiatives.

Conclusion

Syed M Ali's work in glycine transport inhibition showcases his innovative spirit and dedication to advancing pharmaceutical science. His patents and collaborations reflect his significant impact on the field, making him a noteworthy inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…